HUALAN BIOLOGICAL revenue breakdown overview

HUALAN BIOLOGICAL revenue for the last year amounted to 2.41 B CNY, the most of which — 2.40 B CNY — came from its highest performing source at the moment, Influenza Vaccine, the year earlier bringing 1.82 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought HUALAN BIOLOGICAL 2.41 B CNY, and the year before that — 1.83 B CNY.